Featured Posts

Tuesday, February 5, 2019

The liver cancer drugs market will register a CAGR of over 10% by 2023

NEW YORK, Feb. 4, 2019 /PRNewswire/ -- About this market Liver cancer is among the leading causes of cancer-related deaths, globally. The increase in incidence of risk factors like hepatitis B and C and underlying cirrhosis will lead to the rise in risk of liver cancer depending on the...

from PR Newswire: https://prn.to/2WI98Mr

No comments:

Post a Comment